{"cik":2042347,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Seaport Therapeutics, Inc.","units":{"USD":[{"start":"2025-01-01","end":"2025-03-31","val":1619000,"accn":"0001193125-26-260678","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-06-08","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":3375000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03"},{"start":"2025-04-01","end":"2025-06-30","val":1756000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-03-31","val":2569000,"accn":"0001193125-26-260678","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-06-08","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":39432000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03"},{"start":"2026-04-01","end":"2026-06-30","val":36863000,"accn":"0001193125-26-329537","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-03","frame":"CY2026Q2"}]}}